|
|
|
Help, hope and hype: ethical considerations of human microbiome research and applications |
Yonghui Ma1( ), Hua Chen2, Canhui Lan3, Jianlin Ren4,5 |
1. Centre for Bioethics, Medical College, Xiamen University, Xiamen 361102, China
2. Center for Bioethics, School of Marxism, Southern Medical University, Guangzhou 510515, China
3. Beijing Rexinchang Biotechnology Research Institute Co. Ltd, Beijing, China
4. Institute for Human Microbiome Research, Medical College, Xiamen University, Xiamen 361005, China
5. Department of Digestive Diseases, Zhongshan Hospital affiliated to Xiamen University, Xiamen 361004, China |
|
|
|
|
|
|
Corresponding Author(s):
Yonghui Ma
|
|
Issue Date: 08 June 2018
|
|
| 1 |
Balskus EP (2016) Addressing infectious disease challenges by investigating microbiomes. ACS Infect Dis 2(7):453–455
https://doi.org/10.1021/acsinfecdis.6b00100
|
| 2 |
Bannaga AS, Selinger CP (2015) Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clin Exp Gastroenterol 8:111–117
|
| 3 |
Best is yet to come (2011) Nature 470:140.
|
| 4 |
Bik EM (2016) The hoops, hopes, and hypes of human microbiome research. Yale J Biol Med 89(3):363–373
|
| 5 |
Bledsoe MJ (2017) Ethical legal and social issues of biobanking: past, present, and future. Biopreserv Biobank 15(2):142–147
https://doi.org/10.1089/bio.2017.0030
|
| 6 |
Bolan S, Seshadri B, Talley NJ, Naidu R (2016) Bio-banking gut microbiome samples. EMBO Rep 17(7):929–930
https://doi.org/10.15252/embr.201642572
|
| 7 |
Borody TJ, Campbell J (2012) Fecal microbiota transplantation: techniques, applications, and issues. Gastroenterol Clin N Am 41(4):781–803
https://doi.org/10.1016/j.gtc.2012.08.008
|
| 8 |
Brownsword R, Wale J (2017) The right to know and the right not to know revisited: part one. Asian Bioeth Rev 9(1):3–18
|
| 9 |
Burke W, Burton H, Hall AE, Karmali M, Khoury MJ, Knoppers B, Meslin EM, Stanley F, Wright CF, Zimmern RL (2010) Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine? Genet Med 12(12):785–791
https://doi.org/10.1097/GIM.0b013e3182011222
|
| 10 |
Cambon-Thomsen A (2004) The social and ethical issues of postgenomic human biobanks. Nat Rev Genet 5(11):866–873
https://doi.org/10.1038/nrg1473
|
| 11 |
Cammarota G, Ianiro G, Gasbarrini A (2014) Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 48(8):693–702
https://doi.org/10.1097/MCG.0000000000000046
|
| 12 |
Caulfield T (2007) Biobanks and blanket consent: the proper place of the public good and public perception rationales. King’s Law J 18(2):209–226
https://doi.org/10.1080/09615768.2007.11427674
|
| 13 |
Chen Y, Blaser MJ (2007) Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 167(8):821–827
https://doi.org/10.1001/archinte.167.8.821
|
| 14 |
Chu DM, Ma J, Prince AL, Antony KM, Seferovic MD, Aagaard KM (2017) Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med 23:314
https://doi.org/10.1038/nm.4272
|
| 15 |
Chuong KH, Hwang DM, Tullis DE, Waters VJ, Yau YC, Guttman DS, O’Doherty KC (2017) Navigating social and ethical challenges of biobanking for human microbiome research. BMC Med Ethics 18(1):1
https://doi.org/10.1186/s12910-016-0160-y
|
| 16 |
Collins FS (1999) Shattuck lecture–medical and societal consequences of the human genome project. N Engl J Med 341(1):28–37
https://doi.org/10.1056/NEJM199907013410106
|
| 17 |
Costello SP, Tucker EC, La Brooy J, Schoeman MN, Andrews JM (2016) Establishing a fecal microbiota transplant service for the treatment of clostridium difficile infection. Clin Infect Dis 62(7):908–914
https://doi.org/10.1093/cid/civ994
|
| 18 |
Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13(10):701–712
https://doi.org/10.1038/nrn3346
|
| 19 |
Cunnington AJ, Sim K, Deierl A, Kroll JS, Brannigan E, Darby J (2016) “Vaginal seeding” of infants born by caesarean section. BMJ 352
https://doi.org/10.1136/bmj.i227
|
| 20 |
Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human–microbe mutualism and disease. Nature 449:811
https://doi.org/10.1038/nature06245
|
| 21 |
Dominguez-Bello MG, Blaser MJ (2011) The human microbiota as a marker for migrations of individuals and populations. Ann Rev Anthropol 40(1):451–474
https://doi.org/10.1146/annurev-anthro-081309-145711
|
| 22 |
Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci 107(26):11971
https://doi.org/10.1073/pnas.1002601107
|
| 23 |
Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical? Jama 283(20):2701–2711
https://doi.org/10.1001/jama.283.20.2701
|
| 24 |
Francis LP, Battin MP, Jacobson JA, Smith CB, Botkin J (2005) How infectious diseases got left out–and what this omission might have meant for bioethics. Bioethics 19(4):307–322
https://doi.org/10.1111/j.1467-8519.2005.00445.x
|
| 25 |
Franzosa EA, Huang K, Meadow JF, Gevers D, Lemon KP, Bohannan BJ (2015) Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci USA, 112
https://doi.org/10.1073/pnas.1423854112
|
| 26 |
Gligorov N (2013) Privacy, confidentiality, and new ways of knowing more. In: The human microbiome: Ethical, legal and social concerns (Edited by Rosamond Rhodes, Nada Gligorov, Abraham Paul Schwab). Oxford University Press
|
| 27 |
Gligorov N, Azzouni J, Lackey DP, Zweig A (2013) Personal Identity: our microbes, ourselves.In: The human microbiome: ethical, legal and social concerns, Edited by Prosamond Rhodes, Nada Gligorov, And Abraham Paul Schwab, Oxford University Press
|
| 28 |
Hampton-Marcell JT, Lopez JV, Gilbert JA (2017) The human microbiome: an emerging tool in forensics. Microb Biotechnol 10(2):228–230
https://doi.org/10.1111/1751-7915.12699
|
| 29 |
Hanage WP (2014) Microbiology: microbiome science needs a healthy dose of scepticism. Nature 512(7514):247–248
https://doi.org/10.1038/512247a
|
| 30 |
Harrison KL, Farrell RM, Brinich MA, Highland J, Mercer M, McCormick JB, Tilburt J, Geller G, Marshall P, Sharp RR (2015) ‘Someone should oversee it’: patient perspectives on the ethical issues arising with the regulation of probiotics. Health Expect 18(2):250–261
https://doi.org/10.1111/hex.12027
|
| 31 |
Hawkins AK, O’Doherty KC (2011) “Who owns your poop?”: insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. BMC Med Genom 4:72
https://doi.org/10.1186/1755-8794-4-72
|
| 32 |
Honey K (2008) Good bugs, bad bugs: learning what we can from the microorganisms that colonize our bodies. J Clin Invest 118(12):3817
https://doi.org/10.1172/JCI37910
|
| 33 |
Hutter T, Gimbert C, Bouchard F, Lapointe F-J (2015) Being human is a gut feeling. Microbiome 3:9
https://doi.org/10.1186/s40168-015-0076-7
|
| 34 |
Juengst ET, Settersten RA, Fishman JR, McGowan ML (2012) After the revolution? Ethical and social challenges in ‘personalized genomic medicine’. Pers Med 9(4):429–439
https://doi.org/10.2217/pme.12.37
|
| 35 |
Lederberg J (2006) The microbe’s contribution to biology–50 years after. Int Microb 9(3):155–156
|
| 36 |
Lu C, Sang J, He H, Wan X, Lin Y, Li L, Li Y, Yu C (2016) Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis. Sci Rep 6:23522
https://doi.org/10.1038/srep23522
|
| 37 |
Ma B, Forney LJ, Ravel J (2012) The vaginal microbiome: rethinking health and diseases. Ann Rev Microbiol 66:371–389
https://doi.org/10.1146/annurev-micro-092611-150157
|
| 38 |
Ma Y, Liu J, Rhodes C, Nie Y, Zhang F (2017a) Ethical issues in fecal microbiota transplantation in practice. Am J Bioeth 17(5):34–45
https://doi.org/10.1080/15265161.2017.1299240
|
| 39 |
Ma Y, Chen H, Lei R, Ren J (2017b) Biobanking for human microbiome research: promise, risks, and ethics. Asian Bioeth Rev 9(4):311–324
|
| 40 |
Ma Y, Yang J, Cui B, Xu H, Xiao C, Zhang F (2017c) How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study. BMC Med Ethics 18(1):39
https://doi.org/10.1186/s12910-017-0200-2
|
| 41 |
McGuire AL, Colgrove J, Whitney SN, Diaz CM, Bustillos D, Versalovic J (2008) Ethical, legal, and social considerations in conducting the human microbiome project. Genome Res 18(12):1861–1864
https://doi.org/10.1101/gr.081653.108
|
| 42 |
McGuire AL, Achenbaum LS, Whitney SN, Slashinski MJ, Versalovic J, Keitel WA, McCurdy SA (2012) Perspectives on human microbiome research ethics. J Empir Res Hum Res Ethics 7(3):1–14
https://doi.org/10.1525/jer.2012.7.3.1
|
| 43 |
Meadow JF, Altrichter AE, Bateman AC, Stenson J, Brown GZ, Green JL, Bohannan BJ (2015) Humans differ in their personal microbial cloud. PeerJ 3:e1258
https://doi.org/10.7717/peerj.1258
|
| 44 |
Merlo G, Graves N, Brain D, Connelly L (2016) Economic evaluation of fecal microbiota transplantation for the treatment of recurrent clostridium difficile infection in Australia. J Gastroenterol Hepatol 31(12):1927–1932
https://doi.org/10.1111/jgh.13402
|
| 45 |
Nettleton S (2013) The sociology of health and illness, 3rd edn. Polity, Malden
|
| 46 |
Nguyen TL, Vieira-Silva S, Liston A, Raes J (2015) How informative is the mouse for human gut microbiota research? Dis Models Mech 8(1):1–16
https://doi.org/10.1242/dmm.017400
|
| 47 |
O’Doherty KC, Virani A, Wilcox ES (2016) The human microbiome and public health: social and ethical considerations. Am J Public Health 106(3):414–420
https://doi.org/10.2105/AJPH.2015.302989
|
| 48 |
Oh B, Kim BS, Kim JW, Kim JS, Koh SJ, Kim BG, Lee KL, Chun J (2016) The effect of probiotics on gut microbiota during the helicobacter pylori eradication: randomized controlled trial. Helicobacter 21(3):165–174
https://doi.org/10.1111/hel.12270
|
| 49 |
Paramsothy S, Borody TJ, Lin E, Finlayson S, Walsh AJ, Samuel D, van den Bogaerde J, Leong RW, Connor S, Ng Wet al. (2015) Donor recruitment for fecal microbiota transplantation. Inflamm Bowel Dis 21(7):1600–1606
https://doi.org/10.1097/MIB.0000000000000405
|
| 50 |
Ravitsky V, Wilfond BS (2006) Disclosing individual genetic results to research participants. Am J Bioeth 6(6):8–17
https://doi.org/10.1080/15265160600934772
|
| 51 |
Rhodes R (2013) Introduction: looking back and looking forward.In: The human microbiome: ethical, legal and social concerns, Edited by Prosamond Rhodes, Nada Gligorov, And Abraham Paul Schwab, Oxford University Press
|
| 52 |
Rhodes R (2016) Ethical issues in microbiome research and medicine. BMC Med 14(1):156
https://doi.org/10.1186/s12916-016-0702-7
|
| 53 |
Rhodes R, Azzouni J, Baumrin SB, Benkov K, Blaser MJ, Brenner B, Dauben JW, Earle WJ, Frank L, Gligorov Net al. (2011) De minimis risk: a proposal for a new category of research risk. Am J Bioeth 11(11):1–7
https://doi.org/10.1080/15265161.2011.615588
|
| 54 |
Rhodes R, Baumrin SB, Blaser MJ, Earle WJ, Indyk D, Ethylin WJ, Moros DA, Richardson LD, Sacks HS (2013) Public health and research on populations.In: The human microbiome: ethical, legal and social concerns, Edited by Prosamond Rhodes, Nada Gligorov, And Abraham Paul Schwab, Oxford University Press
|
| 55 |
Rodriguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, Avershina E, Rudi K, Narbad A, Jenmalm MCet al. (2015) The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis 26:26050
https://doi.org/10.3402/mehd.v26.26050
|
| 56 |
Rosamond Rhodes MJB, Dauben JW, Frank LE, Moros DE, Philpott S (2013) Research Ethics. The human microbiome: ethical, legal and social concerns, Edited by Prosamond Rhodes, Nada Gligorov, And Abraham Paul Schwab, Oxford University Press
|
| 57 |
Rubin DT, Becker S, Siegler M (2014) Ethical considerations for clinical trials in inflammatory bowel disease. Gastroenterol Hepatol 10(1):37–41
|
| 58 |
Ruth R (1986) Faden TLB: a history and theory of informed consent. Oxford University Press, New York
|
| 59 |
Sanmiguel C, Gupta A, Mayer EA (2015) Gut microbiome and obesity: a plausible explanation for obesity. Curr Obes Rep 4(2):250–261
https://doi.org/10.1007/s13679-015-0152-0
|
| 60 |
Schmedes SE, Sajantila A, Budowle B (2016) Expansion of Microbial Forensics. J Clin Microb 54(8):1964–1974
https://doi.org/10.1128/JCM.00046-16
|
| 61 |
Schulfer A, Blaser MJ (2015) Risks of antibiotic exposures early in life on the developing microbiome. PLoS Pathog 11(7):e1004903
https://doi.org/10.1371/journal.ppat.1004903
|
| 62 |
Schwab AP, Brenner B, Goldfarb J, Hirschhorn R, Philpott S (2013) Biobanks and the human microbiome. In: Rhodes R, Gligorov N, Schwab AP (eds) The human microbiome: ethical, legal and social concerns. Oxford University Press, New York, pp 182–207
|
| 63 |
Schwarz S, Morelli G, Kusecek B, Manica A, Balloux F, Owen RJ, Graham DY, van der Merwe S, Achtman M, Suerbaum S (2008) Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog 4(10):e1000180
https://doi.org/10.1371/journal.ppat.1000180
|
| 64 |
Seeding V (2017) Committee opinion No. 725. American College of obstetricians and gynecologists. Obstet Gynecol 130:e274–e278
|
| 65 |
Senok AC, Ismaeel AY, Botta GA (2005) Probiotics: facts and myths. Clin Microbiol Infect 11(12):958–966
https://doi.org/10.1111/j.1469-0691.2005.01228.x
|
| 66 |
Sharp RR, Achkar J-P, Brinich MA, Farrell RM (2009) Helping patients make informed choices about probiotics: a need for research. Am J Gastroenterol 104(4):809–813
https://doi.org/10.1038/ajg.2008.68
|
| 67 |
Slashinski MJ, McCurdy SA, Achenbaum LS, Whitney SN, McGuire AL (2012) “Snake-oil”, “quack medicine”, and “industrially cultured organisms:” biovalue and the commercialization of human microbiome research. BMC Med Ethics 13:28
https://doi.org/10.1186/1472-6939-13-28
|
| 68 |
Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS (2013) Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections. Am J Gastroenterol 108(4):478–498
https://doi.org/10.1038/ajg.2013.4
|
| 69 |
Terveer EM, van Beurden YH, Goorhuis A, Seegers JFML, Bauer MP, van Nood E, Dijkgraaf MGW, Mulder CJJ, Vandenbroucke-Grauls CMJE, Verspaget HWet al. (2017) How to: establish and run a stool bank. Clin Microbiol Infect 23(12):924–930
https://doi.org/10.1016/j.cmi.2017.05.015
|
| 70 |
Torrey FE, Yolken RH (2005) Beasts of the earth: animals, humans, and disease.In: pISCATAWAY, NJ: Rutgers University Press
|
| 71 |
Tosh PK, McDonald LC (2012) Infection control in the multidrugresistant era: tending the human microbiome. Clin Infect Dis 54(5):707–713
https://doi.org/10.1093/cid/cir899
|
| 72 |
Tridico SR, Murray DC, Addison J, Kirkbride KP, Bunce M (2014) Metagenomic analyses of bacteria on human hairs: a qualitative assessment for applications in forensic science. Investig Genet 5(1):1–13
https://doi.org/10.1186/s13323-014-0016-5
|
| 73 |
Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JPet al. (2009) A core gut microbiome in obese and lean twins. Nature 457 (7228):480–484
https://doi.org/10.1038/nature07540
|
| 74 |
van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JFWM, Tijssen JGPet al. (2013) Duodenal infusion of donor feces for recurrent clostridium difficile. N Engl J Med 368(5):407–415
https://doi.org/10.1056/NEJMoa1205037
|
| 75 |
Varier RU, Biltaji E, Smith KJ, Roberts MS, Kyle Jensen M, LaFleur J, Nelson RE (2015) Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol 36(4):438–444
https://doi.org/10.1017/ice.2014.80
|
| 76 |
Walter J, Ley R (2011) The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol 65:411–429
https://doi.org/10.1146/annurev-micro-090110-102830
|
| 77 |
Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, Zeng L, Chen J, Fan S, Du Xet al. (2016) Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry 21(6):786–796
https://doi.org/10.1038/mp.2016.44
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
